"Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Clobetasol Propionate Foam, 0.05 percent (emulsion formulation)," Glenmark said in a regulatory filing.from Moneycontrol Business News
Read The Rest:moneycontrol...